Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S4 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors
  1. Home
  2. Publications
  3. Table S4 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors

Table S4 from Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors

Authors:
  • JSJun Sato
    Jun Sato
  • YKYuki Katsuya
    Yuki Katsuya
  • TKTakafumi Koyama
    Takafumi Koyama
  • TSToshio Shimizu
    Toshio Shimizu
  • YTYasushi Tanoue
    Yasushi Tanoue
  • MYMaki Yamamoto
    Maki Yamamoto
  • HTHirokazu Tozaki
    Hirokazu Tozaki
  • ETEiji Takahara
    Eiji Takahara
  • SSShingo Shoji
    Shingo Shoji
  • AMAkio Mizutani
    Akio Mizutani
  • DMDaisuke Morishita
    Daisuke Morishita
  • RORobert W. Oda
    Robert W. Oda

Open Access
Publisher website
Google Scholar
  • 3 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33143259
Abstract
All TRAEs occurring in ≥10% of patients with solid tumors.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • GENE REGULATION
  • RNA SPLICING
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.